Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 15, 2023 - Issue
Submit an article Journal homepage
214
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Pregnancy Associated Invasive Apocrine Carcinoma of the Breast: Case Report from Ethiopia

Haimanot Kasahun Alemu1 Department of Internal Medicine, Oncology Unit; Saint Paul’s Hospital Millennium Medical College, Addis Ababa, EthiopiaCorrespondence[email protected]
,
Nazik Hammad2 Department of Medical Oncology, Queen’s University, Kingston, Ontario, Canada
,
Mesfin Asefa Tola3 Department of Pathology; Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
&
Verna Vanderpuye4 National Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, Accra, Ghana
Pages 429-433 | Received 04 Feb 2023, Accepted 14 Jun 2023, Published online: 23 Jun 2023

References

  • Antonelli NM, Dotters DJ, Katz VL, Kuller JA. Cancer in pregnancy: a review of the literature. Part 1. Obstet Gynecol Surv. 1996;51(2):125–134. doi:10.1097/00006254-199602000-00022
  • Nicholas AP. Coexistence of pregnancy and malignancy. Oncologist. 2002;7(4):279–287. doi:10.1634/theoncologist.2002-0279
  • Taylor L, Harris C, Abebe T, Addissie A, Assefa M, Kantelhardt EJ. A decade of strengthening breast oncology in Ethiopia. Lancet. 2021;22:1219–1220.
  • Vranic S, Feldman R, Gatalica Z. Apocrine Carcinoma of the breast: a brief update on the molecular features and targetable biomarkers. BJBMS. 2017;17(1):9–11.
  • Memirie ST, Habtemariam MK, Asefa M, et al. Estimates of cancer incidence in Ethiopia in 2015 using population based registration data. JCO Glob Oncol. 2018;4:1–11.
  • Kantelhardt EJ, Mathewos A, Aynalem A, et al. The prevalence of estrogen receptor negative breast cancer in Ethiopia. BMC Cancer. 2014;14(1):895. doi:10.1186/1471-2407-14-895
  • Ayele W, Führer A, Braun GA, et al. Breast cancer morbidity and mortality in rural Ethiopia: data from 788 verbal autopsies. BMC Womens Health. 2022;22:89. doi:10.1186/s12905-022-01672-7
  • DeSantis CE, Ma J, Guadet MM, et al. Breast Cancer Statistics, 2019. CA. 2019;69:435–451. doi:10.3322/caac.21581
  • Tesfaw A, Alebachew W, Tiruneh M. why women with breast cancer present late to health care facility in North-West Ethiopia? A qualitative Study. PLoS One. 2020;15:e0243551. doi:10.1371/journal.pone.0243551
  • Ishida T, Yokoe T, Kasumi F, et al. Clinicopathologic Characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res. 1992;83(11):1143. doi:10.1111/j.1349-7006.1992.tb02737.x
  • Jeanne A, Petrek MD. Breast cancer during pregnancy. Cancer. 1994;74(51):518–527. doi:10.1002/cncr.2820741341
  • Poggio F, Tagliamento M, Pirrone C, et al. Update on the management of breast cancer during pregnancy. Cancers. 2020;12(12):3616. doi:10.3390/cancers12123616
  • Amant F, Loibl S, Neven P, Calsteren KV. Malignancies in pregnancy 2: breast cancer in pregnancy. Lancet. 2012;379:570–579. doi:10.1016/S0140-6736(11)61092-1
  • Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol. 2003;21(3):555–563. doi:10.1200/JCO.2003.04.171
  • Peccatori FA, Azim HA Jr, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow up. Ann Oncol. 2013;24(6):160–170. doi:10.1093/annonc/mdt199
  • Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer study: a report from the childhood cancer survivor study. JNCI. 2006;98(13):890–896. doi:10.1093/jnci/djj243
  • Mccollough CH, Schueler BA, Atwell TD, et al. Radiation exposure and pregnancy: when should we be concerned? RSNA. 2007;27(4):909–917.
  • Shetty MK. Abdominal computed tomography during pregnancy: a review indications and fetal radiation exposure issues. Semin Ultrasound CT MR. 2010;31:3–7. doi:10.1053/j.sult.2009.09.001
  • Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer. 1999;86(11):2266. doi:10.1002/(SICI)1097-0142(19991201)86:11<2266::AID-CNCR14>3.0.CO;2-7
  • Zemelickis D, Lishner M, Dogendorfer P, et al. Maternal and Fetal outcome after in utero exposure to cancer chemotherapy. AMJ Obstet Gynecol. 1992;166(30):781. doi:10.1016/0002-9378(92)91334-7
  • Chang JH, Vines E, Bertsch H, et al. The impact of multidisciplinary breast cancer center on recommendations for patient management. Cancer. 2001;91(70):1231–1237. doi:10.1002/1097-0142(20010401)91:7<1231::AID-CNCR1123>3.0.CO;2-K
  • Gonzalez–Angulo AM, Litton JK, Broglio KR, et al. High Risk of recurrence for patients with breast cancer who have human epidermal growth factor 2-positive node negative tumors 1cm or smaller. JCO. 2009;34:5700–5706. doi:10.1200/JCO.2009.23.2025
  • Zhong A, Darren B, Loiseau B, et al. Ethical, Social and Cultural issues related to clinical genetic testing and counseling in low and middle-income countries: a systematic review. Genet Med. 2018;23:2270–2280.
  • Elledge RM, Ciocca DR, Langone G, McGuire WL. Estrogen receptor, progesterone receptor and HER-2/new protein in breast cancer from pregnant patients. Cancer. 1993;71(8):2499.
  • Dellapasqua S, Maisonneuve P, Viale G, et al. Immunohistochemically defined subtypes and outcome of apocrine breast cancer. Clin Breast Cancer. 2013;13(2):95–102.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.